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ABSTRACT 
 
 
 
Guo, Xia. M.S.B.M.E., Purdue University, December 2010. Preparation and Evaluation 
of Antibacterial Dental Glass-ionomer Cements. Major Professor: Dong Xie. 
 
 
 
The functional quaternary ammonium salts (QAS) and their constructed polyQAS 
or PQAS were synthesized, characterized and formulated into a novel antibacterial glass-
ionomer cement. Compressive strength (CS) and Streptococcus mutans (S. mutans) 
viability were used to evaluate the mechanical strength and antibacterial activity of the 
cements. Fuji II LC cement was used as control. The specimens were conditioned in 
distilled water at 37 
o
C for 24 h prior to testing. The effects of the substitute chain length, 
loading as well as grafting ratio of the QAS and aging on CS and S. mutans viability were 
investigated. 
 
Chapter 2 describes how we studied and evaluated the formulated antibacterial 
glass-ionomer cement by incorporating QAS chloride-containing polymer into the 
formulation. The results show that with PQAS addition, the studied cements showed a 
reduction in CS with 25-95% for Fuji II LC and 13-78% for the experimental cement and 
a reduction in S. mutans viability with 40-79% for Fuji II LC and 40-91% for the 
experimental cement. The experimental cement showed less CS reduction and higher 
antibacterial activity as compared to Fuji II LC. The long-term aging study indicates that 
the cements are permanently antibacterial with no PQAS leaching. 
 
Chapter 3 describes how we studied and evaluated the formulated antibacterial 
cements by changing chain length, type of halide, loading, grafting ratio and aging time. 
The results show that the effects of the chain length, loading and grafting ratio of the 
ix 
 
QAS were significant. Increasing chain length, loading, grafting ratio significantly 
enhanced antibacterial activity but reduced CS. The experimental cement showed less CS 
reduction and higher antibacterial activity as compared to Fuji II LC. The long-term 
aging study indicates that the cements are permanently antibacterial with no PQAS 
leaching. There was no significant difference between QAS bromide and QAS chloride, 
suggesting that we can use QAS bromide directly without converting bromide to chloride. 
 
In summary, we have developed a novel PQAS-containing antibacterial glass-
ionomer cement. The cement has demonstrated significant antibacterial activities. Our 
experimental cement is a promising system because the reduced strength of the cement 
with addition of PQAS is still above those demonstrated by original commercial cement 
Fuji II LC without any PQAS addition. It appears that the experimental cement is a 
clinically attractive dental restorative that can be potentially used for long-lasting 
restorations due to its high mechanical strength and permanent antibacterial function. 
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1. INTRODUCTION 
 
 
1.1  Background 
It is known that both restorative materials and oral bacteria are mainly responsible 
for the restoration failure. Secondary caries is found to be the main reason to the 
restoration failure of either composite resins or glass-ionomer cements (GICs). Secondary 
caries that often occurs at the interface between the restoration and the cavity preparation 
is mainly caused by demineralization of tooth structure due to invasion of plaque bacteria 
(acid-producing bacteria) such as Streptococcus mutans (S. mutans) in the presence of 
fermentable carbohydrates. Among all the dental restoratives, GICs are found to be the 
most cariostatic and somehow antibacterial due to release of fluoride, which is believed 
to help reduce demineralization, enhance remineralization and inhibit microbial growth. 
However, annual clinical surveys found that secondary caries was still the main reason 
for GIC failure, indicating that the fluoride-release from GICs is not potent enough to 
inhibit bacterial growth or combat bacterial destruction. Although numerous efforts have 
been made on improving antibacterial activities of dental restoratives, most of them have 
been focused on release or slow-release of various incorporated low molecular weight 
antibacterial agents such as antibiotics, zinc ions, silver ions, iodine and chlorhexidine. 
However, release or slow-release can lead or has led to a reduction of mechanical 
properties of the restoratives over time, short-term effectiveness, and possible toxicity to 
surrounding tissues if the dose or release is not properly controlled. 
 
Polymers containing quaternary ammonium (QAS) or phosphonium salt (QPS) 
groups have been studied extensively as an important antimicrobial material and used for 
a variety of applications due to their potent antimicrobial activities. These polymers are 
found to be capable of killing bacteria that are resistant to other types of cationic 
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antibacterials. The examples of polyQAS or PQAS used as antibacterials for dental 
restoratives include incorporation of a methacryloyloxydodecyl pyridinium bromide as an 
antibacterial monomer into composite resins and incorporation of quaternary ammonium
polyethylenimine nanoparticles into composite resins. All these studies found that PQAS 
did exhibit significant antibacterial activities. However, so far there have been no reports 
on using PQAS as an antibacterial agent for GICs. 
 
 
1.2. Hypothesis and Objectives 
It is our hypothesis that incorporating PQAS into current or experimental glass-
ionomer cement would provide a novel route for formulation of a novel antibacterial 
glass-ionomer cement for improved dental restoratives.   
 
The objectives of the study in this thesis were: (1) to synthesize and characterize 
QAS and PQAS; (2) to formulate the GIC with the synthesized PQAS; (3) to evaluate the 
mechanical strengths of the formed cements; and (4) to evaluate the antibacterial activity 
of the formulated cements. Commercial Fuji II LC and recently developed experimental 
high-strength cements were used as controls. 
 
Chapter 2 mainly describes the synthesis, characterization, formulation and 
evaluation of the cements composed of QAS chloride-containing polymers. Chapter 3 
mainly describes the synthesis, characterization, formulation and evaluation of the 
cements composed of QAS bromide-containing polymers. The effects of chain length, 
type of halide, loading, grafting ratio and aging time on compressive strength and S. 
mutans viability were also investigated. 
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2. A PQAS-CONTAINING GLASS-IONOMER CEMENT FOR IMPROVED 
ANTIBACTERIAL FUNCTION 
 
 
2.1  Abstract 
The novel non-leachable poly(quaternary ammonium salt) (PQAS)-containing 
antibacterial glass-ionomer cement has been developed.  Compressive strength (CS) and 
S. mutans viability were used as tools for strength and antibacterial activity evaluations, 
respectively. All the specimens were conditioned in distilled water at 37 
o
C prior to 
testing. Commercial glass-ionomer cement Fuji II LC was used as control. With PQAS 
addition, the studied cements showed a reduction in CS with 25-95% for Fuji II LC and 
13-78% for the experimental cement and a reduction in S. mutans viability with 40-79% 
for Fuji II LC and 40-91% for the experimental cement. The experimental cement 
showed less CS reduction and higher antibacterial activity as compared to Fuji II LC. The 
long-term aging study indicates that the cements are permanently antibacterial with no 
PQAS leaching. It appears that the experimental cement is a clinically attractive dental 
restorative that can be potentially used for long-lasting restorations due to its high 
mechanical strength and permanent antibacterial function. 
 
 
2.2  Introduction 
In dental clinics, secondary caries is found to be the main reason to the restoration 
failure of either composite resins or glass-ionomer cements (GICs) [1-4]. Secondary 
caries that often occurs at the interface between the restoration and the cavity preparation 
is mainly caused by demineralization of tooth structure due to invasion of plaque bacteria 
(acid-producing bacteria) such as Streptococcus mutans (S. mutans) in the presence of 
fermentable carbohydrates [4]. Among all the dental restoratives, GICs are 
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found to be the most cariostatic and somehow antibacterial due to release of fluoride, 
which is believed to help reduce demineralization, enhance remineralization and inhibit 
microbial growth [5, 6]. However, annual clinical surveys found that secondary caries 
was still the main reason for GIC failure [1-4], indicating that the fluoride-release from 
GICs is not potent enough to inhibit bacterial growth or combat bacterial destruction. 
Although numerous efforts have been made on improving antibacterial activities of dental 
restoratives, most of them have been focused on release or slow-release of various 
incorporated low molecular weight (MW) antibacterial agents such as antibiotics, zinc 
ions, silver ions, iodine and chlorhexidine (CHX) [6-10]. However, release or slow-
release can lead or has led to reduction of mechanical properties of the restoratives over 
time, short-term effectiveness, and possible toxicity to surrounding tissues if the dose or 
release is not properly controlled [6-10]. 
 
Macromolecules containing quaternary ammonium (QAS) or phosphonium salt 
(QPS) groups have been studied extensively as an important antimicrobial material and 
used for a variety of applications due to their potent antimicrobial activities [11-15]. 
These polymers are found to be capable of killing bacteria that are resistant to other types 
of cationic antibacterials [16]. The examples of polyQAS or PQAS used as antibacterials 
for dental restoratives include incorporation of a methacryloyloxydodecyl pyridinium 
bromide (MDPB) as an antibacterial monomer into composite resins [13], use of DMAE-
CB as a component for antibacterial bonding agents [17, 18], and incorporation of 
quaternary ammonium polyethylenimine (PEI) nanoparticles into composite resins [19]. 
All these studies found that PQAS did exhibit significant antibacterial activities. So far 
there have been no reports on using PQAS as an antibacterial agent for GICs. 
 
The objective of this study was to synthesize a new poly(acrylic acid-co-itaconic 
acid) with pendent quaternary ammonium salt (PQAS) and explore the effects of this 
PQAS on mechanical strength and antibacterial activity of commercial Fuji II LC and 
recently developed experimental high-strength cements. 
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2.3  Matrerials and Methods 
 
 
2.3.1  Materials 
2-dimethylaminoethanol (DMAE), bromotetradecane (BT), dipentaerythritol, 2-
bromoisobutyryl bromide (BIBB), acrylic acid (AA), itaconic acid (IA), 2,2’-
azobisisobutyronitrile (AIBN), triethylamine (TEA), CuBr, N,N,N’,N’,N’’-
pentamethyldiethylenetriamine (PMDETA), dl-camphoroquinone (CQ), 2-
(dimethylamino)ethyl methacrylate (DMAEMA), pyridine, tert-butyl acrylate (t-BA), 
glycidyl methacrylate (GM), hydrochloric acid (HCl, 37%), N,N'-
dicyclohexylcarbodiimide (DCC), pyridine, diethyl ether, dioxane, N,N-
dimethylformamide (DMF), methanol (MeOH), ethyl acetate (EA), hexane and 
tetrahydrofuran (THF) were used as received from VWR International Inc (Bristol, CT) 
without further purifications. Light-cured glass-ionomer cement Fuji II LC and Fuji II LC 
glass powders were used as received from GC America Inc (Alsip, IL). Z100 resin 
composite was used as received from 3M ESPE (St. Paul, MN). 
  
 
2.3.2  Synthesis of the Quaternary Ammonium Aalt (QAS) 
The hydroxyl group-containing quaternary ammonium salt (QAS) was 
synthesized following the procedures described elsewhere with a slight modification [12]. 
Briefly, to a flask containing DMAE (0.056 mol) in methanol (100 ml), BT (0.062 mol) 
was added. The reaction was run at room temperature overnight. After most of methanol 
was removed, the mixture was washed with hexane 3 times. The formed 2-dimethyl-2-
tetradecanyl-1-hydroxyethyl ammonium bromide (DTHAB) was then dissolved in 10% 
HCl aqueous solution containing a small amount of MeOH. After the solution was stirred 
at 110 
o
C for 3 h, MeOH, HBr and water were removed via a rotary evaporator. The 
formed 2-dimethyl-2-tetradecanyl-1-hydroxyethyl ammonium chloride (DTHAC) was 
purified by washing with hexane several times before drying in a vacuum oven. The 
synthesis scheme is shown in Figure 2.1. 
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Figure 2.1  Schematic diagrams for synthesis of poly(AA-co-IA) with pendent QAS or 
PQAS and chemical structure of the 6-arm star-shape poly(acrylic acid) tethered with 
methacylate groups: (A): synthesis of PQAS; (B) chemical structure of the 6-arm star-
shape poly(acrylic acid) tethered with polymerizable methacrylates. 
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2.3.3  Synthesis of the Poly(acrylic acid-co-itaconic acid) with Pendent QAS  
The linear poly(acrylic acid-co-itaconic acid) or poly(AA-co-IA) was prepared 
following our published procedures [20].  Briefly, to a flask containing a solution of AA 
(0.08 mol) and IA (0.04 mol) in 40 ml THF, AIBN (0.5 mmol) in 10 ml THF was added. 
After the reaction was run under N2 purging at 60 
o
C for 18 h, poly(AA-co-IA) was 
precipitated with ether, followed by drying in a vacuum oven. Then DTHAC was tethered 
onto the purified poly(AA-co-IA) [21]. Briefly, to a solution of poly(AA-co-IA) in DMF, 
DTHAC was added with DCC and pyridine. The reaction was kept at room temperature 
overnight. After the insoluble dicyclohexyl urea was filtered off, the formed poly(AA-co-
IA) with pendent QAS or PQAS was purified by precipitation from ether, washing with 
ether and drying in a vacuum oven prior to use (see Figure 2.1). 
 
 
2.3.4  Synthesis of the GM-tethered Star-shape Poly(acrylic acid) 
The GM-tethered 6-arm star-shape poly(acrylic acid) (PAA) was synthesized 
similarly as described in our previous publication [22]. Briefly, dipentaerythritol (0.06 
mol) in 200 ml THF was used to react with BIBB (0.48 mol) in the presence of TEA 
(0.35 mol) to form the 6-arm initiator. t-BA (0.078 mol) in 10 ml dioxane was then 
polymerized with the 6-arm initiator (1% by mole) at 120 °C in the presence of CuBr 
(3%)-PMDETA (3%) catalyst complex via ATRP. The resultant 6-arm poly(t-BA) was 
hydrolyzed with HCl and dialyzed against distilled water. The purified star-shape PAA 
was obtained via freeze-drying, followed by tethering with GM (50% by mole) in DMF 
in the presence of pyridine (1% by weight) [22]. The GM-tethered star-shape PAA was 
recovered by precipitation from diethyl ether, followed by drying in a vacuum oven at 
room temperature. The synthesis scheme for the 6-arm star-shape PAA is also shown in 
Figure 2.1. 
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2.3.5  Characterization 
The chemical structures of the synthesized QAS and PQAS were characterized by 
Fourier transform-infrared (FT-IR) spectroscopy and nuclear magnetic resonance (NMR) 
spectroscopy. The proton NMR (
1
HNMR) spectra were obtained on a 500 MHz Bruker 
NMR spectrometer (Bruker Avance II, Bruker BioSpin Corporation, Billerica, MA) using 
deuterated dimethyl sulfoxide and chloroform as solvents and FT-IR spectra were 
obtained on a FT-IR spectrometer (Mattson Research Series FT/IR 1000, Madison, WI). 
 
 
2.4  Evaluation 
 
 
2.4.1  Sample Preparation for Strength Tests 
The experimental cements were formulated with a two-component system (liquid 
and powder) [22]. The liquid was formulated with the light-curable star-shape poly(acrylic 
acid), water, 0.9% CQ (photo-initiator, by weight) and 1.8% DC (activator). The 
polymer/water (P/W) ratios (by weight) = 70:30. Fuji II LC glass powder was either used 
alone or mixed with the synthesized PQAS to formulate the cements, where the PQAS 
mixing ratio (by weight) = 1, 3, 5, 10, or 30% of the glass. The detailed formulations are 
shown in Table 2.1. Fuji II LC and Z100 were used as controls and prepared per 
manufacturers’ instructions, where the P/L ratio = 3.2 for Fuji II LC and premixed paste 
for Z100. 
 
Specimens were fabricated at room temperature according to the published 
protocol [22]. Briefly, the cylindrical specimens were prepared in glass tubing with 
dimensions of 4 mm in diameter by 8 mm in length for compressive strength (CS), 4 mm 
in diameter by 2 mm in length for diametral tensile strength (DTS) and 4 mm in diameter 
by 2 mm in depth for antibacterial tests. All the specimens were exposed to blue light 
(EXAKT 520 Blue Light Polymerization Unit, EXAKT Technologies, Inc., Oklahoma 
City, OK) for 2 min, followed by conditioned in 100% humidity for 15 min, removed 
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from the mold and conditioned in distilled water at 37 
o
C for 24 h unless specified, prior 
to testing. 
 
 
2.4.2  Strength Measurements 
CS and DTS tests were performed on a screw-driven mechanical tester (QTest 
QT/10, MTS Systems Corp., Eden Prairie, MN), with a crosshead speed of 1 mm/min. 
Six to eight specimens were tested to obtain a mean value for each material or formulation 
in each test. CS was calculated using an equation of CS = P/r2, where P = the load at 
fracture and r = the radius of the cylinder. DTS was determined from the relationship 
DTS = 2P/dt, where P = the load at fracture, d = the diameter of the cylinder, and t = the 
thickness of the cylinder. 
 
 
2.4.3  Antibacterial Test 
The antibacterial test was conducted following the published procedures [23]. S. 
mutans (oral bacterial strain) was used for evaluation of antibacterial activity of the 
studied cements. Briefly, colonies of S. mutans (UA159) were suspended in 5 ml of 
Tryptic soy Broth (TSB), supplemented with 1% sucrose. Specimens pretreated with 
ethanol were incubated with S. mutans in TSB at 37 
o
C for 48 h under anaerobic 
condition with 5% CO2. After equal volumes of the red and the green dyes were 
combined in a microfuge tube and mixed thoroughly for 1 min, 3 μl of the dye mixture 
was added to 1 ml of the bacteria suspension, mixed by vortexing for 10 sec, sonicating 
for 10 sec as well as vortexing for another 10 sec, and kept in dark for about 15 min, prior 
to analysis. Then 20 μl of the stained bacterial suspension was analyzed using a 
fluorescent microscope (Nikon Microphot-FXA, Melville, NY). Triple replica was used 
to obtain a mean value for each material. 
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2.4.4  Statistical Analysis 
One-way analysis of variance (ANOVA) with the post hoc Tukey-Kramer 
multiple-range test was used to determine significant differences of both CS and 
antibacterial tests among the materials in each group. A level of α = 0.05 was used for 
statistical significance. 
 
 
2.5  Results and Discussion 
 
 
2.5.1  Characterization 
Figure 2.2 shows the 
1
HNMR spectra for BT, DMEA, DTHAC, poly(AA-co-IA) 
and poly(AA-co-IA) with pendent QAS or PQAS. The characteristic chemical shifts 
(ppm) are shown below: BT: 3.35 (-CH2Br), 1.80 (-CH2CH2Br), 1.38 (-CH2-, all) and 
0.89 (-CH3); DMEA: 4.40 (-OH), 3.42 (-CH2OH), 2.30 (-CH2N-) and 2.10 (H3CN-); 
DTHAC: 5.30 (-OH), 3.82 (-CH2OH), 3.35-3.45 (-CH2N(CH3)2), 3.10 (H3CN-), 1.65 (-
CH2CH2N(CH3)2), 1.25 (-CH2- all) and 0.89 (-CH3); poly(AA-co-IA): 12.2 (-COOH), 
3.45 (-CH(COOH)-) and 1.2-2.5 (-CH2-, all); PQAS: 3.80 (-CH2(COOH)-), 3.30-3.45 (-
CH2N-), 3.10 (H3CN-), 1.65 (-CH2CH2N(CH3)2), 1.25 (-CH2- all) and 0.89 (-CH3). The 
appearance of all the new peaks in the spectrum at the top of Figure 2 confirmed the 
successful attachment of DTHAC onto the poly(AA-co-IA).    
 
Figure 2.3 shows the FT-IR spectra for BT, DMEA, DTHAC, poly(AA-co-IA) 
and PQAS. The characteristic peaks (cm
-1
) are listed below: BT: 2924 (C-H stretching on 
-CH2-), 2853 (C-H stretching on -CH3), 1466, 1377 and 1251 (C-H deformation on –
CH2-), 721 and 647 (C-Br deformation); DMEA: 3399 (O-H stretching), 2944 (C-H 
stretching on -CH2-), 2861 (C-H stretching on -CH3), 2820 and 2779 (C-H stretching on –
N(CH3)2), 1459, 1364 and 1268 (C-H deformation on –CH2-), 1090 (O-H deformation), 
1040 and 776 (C-N deformation); DTHAC: 3349 and 3248 (=N
+
= stretching), 2917 (C-H 
stretching on -CH2-), 2850 (C-H stretching on -CH3), 1470 (C-H deformation on –CH2-), 
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1090 and 730 (O-H deformation); poly(AA-co-IA): 3800-2400 (O-H stretching on –
COOH), 1716 (-C=O stretching), 1196-1458 (C-H deformation on –CH2-); PQAS: 3353 
(=N
+
= stretching), 3800-2400 (O-H stretching on –COOH), 2923 (C-H stretching on -
CH2-), 2853 (C-H stretching on -CH3), 1732 (-C=O stretching), 1167-1466 (C-H 
deformation on –CH2-) and 776 (C-N deformation). The significant peaks at 3353 for 
=N
+
= group, 2923 and 2853 for –CH2- group and 1736 for carbonyl group confirmed the 
formation of PQAS. 
 
 
Figure 2.2  
1
HNMR spectra for BT, DMEA, DTHAC, poly(AA-co-IA) and PQAS: (a) BT; 
(b) DMEA; (c) DTHAC; (d) poly(AA-co-IA) and (e) PQAS. 
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Figure 2.3  FT-IR spectra for BT, DMEA, DTHAC, poly(AA-co-IA) and PQAS: (a) BT; 
(b) DMEA; (c) DTHAC; (d) poly(AA-co-IA) and (e) PQAS. 
 
 
2.5.2  Evaluation 
Table 2.1 shows the codes, materials and formulations used in this study. Both 
Fuji II LC and experimental (EXPGIC) cements with and without PQAS were evaluated. 
PQAS was incorporated in a ratio of 1, 3, 5, 10 and 30% (by weight) of the total glass 
fillers. 
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Table 2.1  Materials and formulations used in the study 
 
Code Liquid formulation1 PQAS % (by weight)2 P/L ratio (by weight)3 
FIILC N/A 0 3.2 
FIILC (1%) N/A 1 3.2 
FIILC (3%) N/A 3 3.2 
FIILC (5%) N/A 5 3.2 
FIILC (10%) N/A 10 3.2 
FIILC (30%) N/A 30 3.2 
EXP 70/30 0 2.7 
EXP (1%) 70/30 1 2.7 
EXP (3%) 70/30 3 2.7 
EXP (5%) 70/30 5 2.7 
EXP (10%) 70/30 10 2.7 
EXP (30%) 70/30 30 2.7 
1
Liquid formulation: N/A = not available; Liquid for EXP = 6-arm star-shape poly(acrylic 
acid) vs. water (by weight); 
2
PQAS = poly(AA-co-IA) with pendent QAS; PQAS was 
mixed with Fuji II LC filler; 0 = only Fuji II LC filler was used; 
3
P/L ratio = a total 
amount of glass filler powder (Fuji II LC glass + PQAS) vs. polymer liquid. 
 
Figure 2.4 shows the mean CS values of Fuji II LC and EXPGIC cements with 
and without PQAS addition. The CS value (MPa) was in the decreasing order of 
EXPGIC > EXPGIC (1%) > EXPGIC (3%) > Fuji II LC > EXPGIC (5%) > Fuji II LC 
(1%) > Fuji II LC (3%) > EXPGIC (10%) > Fuji II LC (5%) > Fuji II LC (10%) > 
EXPGIC (30%) > Fuji II LC (30%). There were no statistically significant differences 
between EXPGIC (3%) and Fuji II LC and between Fuji II LC (3%) and EXPGIC (10%) 
(p > 0.05). Increasing PQAS decreased the CS values of both cements. However, the 
decreasing rate for Fuji II LC was much faster than that for EXPGIC. With 1 to 10% 
PQAS addition, Fuji II LC decreased 25 to 78% of its original CS whereas EXPGIC only 
decreased 12 to 57%. Table 2.2 shows the results of yield strength (YS), compressive 
modulus, CS and DTS. The same trend was observed in Table 2.2 as shown in Figure 2.4. 
With 1 to 10% PQAS addition, Fuji II LC showed a decrease of 26-82% in YS, 22-78% 
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in modulus and 12-70% in DTS, which decreased much faster than EXPGIC (1.9-43% in 
YS, 2.7-34% in modulus and 1.5-43% in DTS). Figure 2.5 shows the effect of the cement 
aging on CS. After one month of aging in water, all the cements showed an increase in 
CS, especially from 1 h to 1 day. There was a slight increase (statistically no difference) 
for each formulation tested from 1 day to 1 week and from 1 week to 1 month. 
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Figure 2.4  CS of Fuji II LC and experimental cements with and without PQAS addition: 
FIILC = Fuji II LC; EXP = EXPGIC; For Fuji II LC cements, P/L = 3.2; Filler = Fuji II 
LC or Fuji II LC + PQAS. For experimental cements, MW of the 6-arm poly(acrylic acid) 
= 17,530 Daltons; Filler = Fuji II LC or Fuji II LC + PQAS; Grafting ratio = 50%; P/L 
ratio = 2.7; P/W ratio = 70:30. Specimens were conditioned in distilled water at 37 
o
C for 
24 h prior to testing. 
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Table 2.2  YS, modulus, CS and DTS of Fuji II LC and EXP cements 
 
Material YS1 [MPa] Modulus [GPa] CS2 [MPa] DTS3 [MPa] 
FIILC 138.4 (2.2)a, 4 6.91 (0.42)d 237.9 (4.5)g 43.4 (4.5) 
FIILC (1%) 101.3 (2.9)b 5.40 (0.09)e 179.6 (1.2) 38.3 (4.6) 
FIILC (3%) 86.4 (5.2)b 4.53 (0.01) 149.8 (1.4)h 29.6 (1.8)i 
FIILC (5%) 50.4 (2.6) 3.22 (0.24) 91.6 (2.7) 24.3 (1.5) 
FIILC (10%) 24.4 (2.6) 1.54 (0.09) 52.3 (2.9) 12.9 (0.3) 
EXP 173.9 (7.1)c 7.74 (0.04)f 325.3 (4.2) 58.8 (0.2)j 
EXP (1%) 170.6 (5.5)c 7.53 (0.16)f 284.4 (15) 57.9 (2.2)j 
EXP (3%) 173.9 (10)c 7.25 (0.13)d, f 253.7 (11)g 50.3 (1.7)k 
EXP (5%) 137.7 (12)a 6.68 (0.08)d 212.0 (4.1)g 49.9 (3.8)k 
EXP (10%) 98.8 (2.6)b 5.09 (0.09)e 136.9 (6.7)h 33.7 (2.2)i 
1
YS = CS at yield; 
2
CS = ultimate CS; 
3
DTS = diametral tensile strength; 
4
Entries are 
mean values with standard deviations in parentheses and the mean values with the same 
superscript letter were not significantly different (p > 0.05). Specimens were conditioned 
in distilled water at 37 
o
C for 24 h prior to testing. 
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Figure 2.5  Effect of aging on CS: The formulations were the same as those described in 
Figure 2.4 Specimens were conditioned in distilled water at 37 
o
C for 1 h, 1 day, 1 week 
and 1 month prior to CS testing. 
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Figure 2.6 shows the mean S. mutans viability values after culturing with Fuji II 
LC and EXPGIC with and without PQAS addition. The mean S. mutans viability was in 
the decreasing order of Z100 > Fuji II LC > EXPGIC > Fuji II LC (1%) > EXPGIC 
(1%) > Fuji II LC (3%) > Fujii II LC (5%) > Fuji II LC (10%) = EXPGIC (3%) > 
EXPGIC (5%) > EXPGIC (10%) > Fuji II LC (30%) > EXPGIC (30%). There were no 
statistically significant differences among Z100, Fuji II LC and EXPGIC, among Fuji II 
LC (1%), Fuji II LC (3%) and EXPGIC (1%), among Fuji II LC (5%), Fuji II LC (10%) 
and EXPGIC (3%), and among Fuji II LC (30%), EXPGIC (5%) and EXPGIC (10%) 
(10%) (p > 0.05). Increasing PQAS decreased the S. mutans viability. With 3 to 30% 
PQAS addition, Fuji II LC killed 45 to 79% of S. mutans whereas EXPGIC killed 63 to 
91%, indicating that the killing power of EXPGIC was much higher than that for Fuji II 
LC. Figure 2.7 shows the effect of the cement aging on the S. mutans viability. No 
significant changes in the S. mutans viability were found for each formulation tested 
except Fuji II LC and EXP, where the S.mutans viability was significantly higher in 1 day 
than in either 3 days or 1 week (p > 0.05). 
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Figure 2.6  The S. mutans viability after culturing with Fuji II LC and experimental 
cements with and without PQAS addition: The formulations were the same as those 
described in Figure 4. Specimens were conditioned in distilled water at 37 
o
C for 24 h, 
followed by incubating with S. mutans before antibacterial testing. 
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Figure 2.7  Effect of aging on the S. mutans viability after culturing with Fuji II LC and 
experimental cements with and without PQAS addition: The formulations were the same 
as those described in Figure 5. The specimens were conditioned in distilled water for 1 
day, 3 days, 1 week and 1 month, followed by incubating with S. mutans before 
antibacterial testing. 
 
 
2.5.3  Discussion 
Currently there is a growing interest in preventing or reducing biofilm formation 
in many biomedical areas. In preventive restorative dentistry, secondary caries is a critical 
issue and prevention of secondary caries plays a key role in long-lasting restorations [1-4]. 
PQAS represents a new trend of antimicrobial agents in biomedical applications [11, 14]. 
PQAS can be incorporated in many ways, including mixing with fillers, copolymerizing 
with other monomers and grafting onto the polymer skeletons [11-15]. The beauty of 
using QAS is that they can kill the microorganism by touch or simple contact. The 
mechanism of QAS to kill bacteria is believed to disrupt the surface membrane of 
bacteria by changing membrane permeability or surface electrostatic balance [12, 19]. 
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Unlike other leachable antibacterial agents such as silver ions, antibiotics, CHX and low 
MW QAS, PQAS are not leachable due to their high MW [15]. In this regard, we 
purposely synthesized the new PQAS, incorporated it into both Fuji II LC and our 
experimental high-strength cements and evaluated the CS and antibacterial function of 
the formed cements. 
 
From the results in Figure 2.4 and Table 2.2, apparently both Fuji II LC and 
EXPGIC cements showed a decrease in CS, YS, modulus and DTS with increasing 
PQAS. This can be attributed to the reason that the incorporated QAS contains a 14 
carbon long chain that does not contribute to any strength enhancement. On the other 
hand, EXPGIC showed a slower decreasing pace with nearly 30% less in CS decrease as 
compared to Fuji II LC (see Figure 2.4). This result implies that there may be some 
strong intermolecular interactions between PQAS and star-shape polymers. Furthermore, 
EXPGIC still kept its CS above 200 MPa at PQAS = 5% or less, which may be attributed 
to its original high strength (325 MPa). 
 
Regarding the antibacterial activity, we also tested a commercial dental composite 
resin Z100 for comparison. We found that Z100 hardly killed S. mutans. After 48 h 
incubation with S. mutans, Z100 only killed 10% S. mutans (see Figure 2.5). Composite 
resins usually do not have antibacterial functions [5, 6]. Both Fuji II LC and EXPGIC 
cements without PQAS addition killed about 20% S. mutans, which can be attributed to 
the release of fluoride. It is known that GICs have inhibitory effects on bacteria due to its 
fluoride release [6]. With PQAS addition, both Fuji II LC and EXPGIC increased their 
antibacterial function significantly. More interestingly, EXPGIC showed an even stronger 
antibacterial activity than Fuji II LC with 3 to 30% PQAS addition. The possible reason 
may be explained below. Since PQAS is composed of 50% carboxylic acid and 50% 
QAS and both components are very hydrophilic, they like to have interactions with other 
hydrophilic components from the cement in the presence of water. EXPGIC contains only 
hydrophilic GM-tethered poly(acrylic acid) (70%) and water (30%), whereas Fuji II LC 
contains a substantial amount (approximately 25-35%) of 2-hydroxyethyl methacrylate 
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(partially hydrophilic) and dimethacrylaye/oligomethacrylte (very hydrophobic), except 
for the linear poly(acrylic acid) (20-30%) and water (20-30%) [24]. Therefore, the 
components in EXPGIC may help the PQAS chains better extend on the surface of the 
cements but dimethacrylaye/oligomethacrylte and 2-hydroxyethyl methacrylate in Fuji II 
LC may restrict or interfere with the extension of the PQAS chains on the surface. 
Obviously, the more the QAS exposed the higher the antibacterial activity anticipated. 
The results imply that to reach the same or similar antibacterial results less PQAS might 
be required for EXPGIC than Fuji II LC. This outcome is very encouraging because it 
will allow us to use the minimum amount of PQAS in EXPGIC to obtain the maximum 
antibacterial activity without significantly reducing mechanical strengths. 
 
As previously discussed, most antibacterial dental materials rely on the release of 
chemicals or antibacterial agents including antibiotics, silver ions, zinc ions, etc [6-10]. 
However, release or slow-release can lead or has led to reduction of mechanical 
properties of the restoratives over time, short-term effectiveness, and possible toxicity to 
surrounding tissues if the dose or release is not properly controlled [6-10]. Our hypothesis 
was to develop an antibacterial glass-ionomer cement without leachable. To confirm if 
the incorporated PQAS was not leachable, we examined both CS and antibacterial 
function of EXPGIC (containing 5% PQAS) after aging in water for 1 day, 3 days, 1 
week and 1 month. The result in Figure 2.5 showed that there was a slight increase in CS 
for all the formulations tested after one month of aging, indicating no PQAS leaching. 
The result in Figure 2.7 showed that there was no change or reduction in antibacterial 
function for all the formulations tested, also suggesting no leaching. Otherwise, both 
strength and antibacterial function would decrease with aging. The reason can be 
attributed to the fact that the PQAS is the polyacid-containing polymer. It is known that 
the carboxylic acid group is the key to GIC setting and salt-bridge formation. The PQAS 
polymer synthesized in the study not only provided QAS for antibacterial function but 
also supplied carboxyl groups for salt-bridge formation. The latter helped the PQAS 
polymer firmly attached to the glass fillers. 
 
20 
 
 
2.6  Conclusions 
We have developed a novel antibacterial glass-ionomer cement containing non-
leachable PQAS. With PQAS addition, both Fuji II LC and experimental cements showed 
a reduction in CS with 25-95% for Fuji II LC and 13-78% for the experimental cement 
and a reduction in S. mutans viability with 40-79% for Fuji II LC and 40-91% for the 
experimental cement. The experimental cement showed less CS reduction and higher 
antibacterial activity as compared to Fuji II LC. The result also indicates that the cements 
are permanently antibacterial with no PQAS leaching. It appears that the experimental 
cement is a clinically attractive dental restorative that can be potentially used for long-
lasting restorations due to its high mechanical strength and permanent antibacterial 
function. 
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3.  SYNTHESIS AND EVALUATION OF AN ANTIBACTERIAL DENTAL CEMENT 
CONTAINING QUATERNARY AMMONIUM BROMIDES 
 
 
3.1  Abstract 
The objective of this study was to synthesize the poly(quaternary ammonium salt) 
(PQAS)-containing polymer, use the polymer to formulate the light-curable glass-
ionomer cements, and evaluate the mechanical strengths and S. mutans viability of the 
formed cements. The functional QAS and their constructed PQAS were synthesized, 
characterized and formulated into both Fuji II LC and experimental high-strength 
cements. Compressive strength (CS) and S. mutans viability were used to evaluate the 
mechanical strength and antibacterial activity of the cements. Fuji II LC cement was used 
as control. The specimens were conditioned in distilled water at 37 
o
C for 24 h prior to 
testing. The effects of the substitute chain length, loading as well as grafting ratio of the 
QAS and aging on CS and cell viability were investigated. The results show that all the 
PQAS-containing cements showed a significant antibacterial activity, accompanying with 
a CS reduction. The effects of the chain length, loading and grafting ratio of the QAS 
were significant. Increasing chain length, loading, grafting ratio significantly enhanced 
antibacterial activity but reduced CS. The experimental cement showed less CS reduction 
and higher antibacterial activity as compared to Fuji II LC. The long-term aging study 
indicates that the cements are permanently antibacterial with no PQAS leaching. There 
was no significant difference between QAS bromide and QAS chloride, suggesting that 
we can use QAS bromide directly without converting bromide to chloride. It appears that 
the experimental cement is a clinically attractive dental restorative that can be potentially 
used for long-lasting restorations due to its high mechanical strength and permanent 
antibacterial function. 
22 
 
3.2  Introduction 
Long-lasting restoratives and restoration are clinically attractive because they can 
reduce patents’ pain and expense as well as the number of their visits to dental offices [1-
4]. It is known that both restorative materials and oral bacteria are mainly responsible for 
the restoration failure [2]. Secondary caries is found to be the main reason to the 
restoration failure of either composite resins or glass-ionomer cements (GICs) [1-4]. 
Secondary caries that often occurs at the interface between the restoration and the cavity 
preparation is mainly caused by demineralization of tooth structure due to invasion of 
plaque bacteria (acid-producing bacteria) such as S. mutans in the presence of 
fermentable carbohydrates [4]. Among all the dental restoratives, GICs are found to be 
the most cariostatic and somehow antibacterial due to release of fluoride, which is 
believed to help reduce demineralization, enhance remineralization and inhibit microbial 
growth [5, 6]. However, annual clinical surveys found that secondary caries was still the 
main reason for GIC failure [1-4], indicating that the fluoride-release from GICs is not 
potent enough to inhibit bacterial growth or combat bacterial destruction. Although 
numerous efforts have been made on improving antibacterial activities of dental 
restoratives, most of them have been focused on release or slow-release of various 
incorporated low molecular weight (MW) antibacterial agents such as antibiotics, zinc 
ions, silver ions, iodine and chlorhexidine (CHX) [6-10]. However, release or slow-
release can lead or has led to a reduction of mechanical properties of the restoratives over 
time, short-term effectiveness, and possible toxicity to surrounding tissues if the dose or 
release is not properly controlled [6-10]. 
 
Polymers containing quaternary ammonium (QAS) or phosphonium salt (QPS) 
groups have been studied extensively as an important antimicrobial material and used for 
a variety of applications due to their potent antimicrobial activities [11-15]. These 
polymers are found to be capable of killing bacteria that are resistant to other types of 
cationic antibacterials [16]. The examples of polyQAS or PQAS used as antibacterials for 
dental restoratives include incorporation of a methacryloyloxydodecyl pyridinium 
bromide (MDPB) as an antibacterial monomer into composite resins [13], use of DMAE-
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CB as a component for antibacterial bonding agents [17, 18], and incorporation of 
quaternary ammonium polyethylenimine (PEI) nanoparticles into composite resins [19]. 
All these studies found that PQAS did exhibit significant antibacterial activities. So far 
there have been no reports on using PQAS as an antibacterial agent for GICs. 
 
The objective of this study was to synthesize a new poly(acrylic acid-co-itaconic 
acid) with pendent quaternary ammonium salt (PQAS) and explore the effects of this 
PQAS on the mechanical strength and antibacterial activity of commercial Fuji II LC and 
recently developed experimental high-strength cements. 
 
 
3.3  Materials and Methods 
 
 
3.3.1  Materials 
2-dimethylaminoethanol (DMAE), bromoethane, bromohexane, bromodecane, 
bromdodecane, bromotetradecane, bromohexadecane, dipentaerythritol, 2-
bromoisobutyryl bromide (BIBB), acrylic acid (AA), itaconic acid (IA), 2,2’-
azobisisobutyronitrile (AIBN), triethylamine (TEA), CuBr, N,N,N’,N’,N’’-
pentamethyldiethylenetriamine (PMDETA), dl-camphoroquinone (CQ), 2-
(dimethylamino)ethyl methacrylate (DMAEMA), pyridine, tert-butyl acrylate (t-BA), 
glycidyl methacrylate (GM), hydrochloric acid (HCl, 37%), N,N'-
dicyclohexylcarbodiimide (DCC), pyridine, diethyl ether, dioxane, N,N-
dimethylformamide (DMF), methanol (MeOH), ethyl acetate (EA), hexane and 
tetrahydrofuran (THF) were used as received from VWR International Inc (Bristol, CT) 
without further purifications. Light-cured glass-ionomer cement Fuji II LC and Fuji II LC 
glass powders were used as received from GC America Inc (Alsip, IL). Z100 resin 
composite was used as received from 3M ESPE (St. Paul, MN). 
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3.3.2  Synthesis of the Quaternary Ammonium Salt (QAS) 
The hydroxyl group-containing quaternary ammonium salt (QAS) was 
synthesized following the procedures described elsewhere with a slight modification [12]. 
Briefly, to a flask containing DMAE (0.056 mol) in methanol (100 ml), bromohexane 
(0.062 mol) was added. The reaction was run at room temperature overnight. After most 
of methanol was removed, the mixture was washed with hexane 3 times. The formed 2-
dimethyl-2-hexyl-1-hydroxyethyl ammonium bromide (or namely B6) was purified by 
dissolving in methanol and washing with hexane several times before drying in a vacuum 
oven. The synthesis scheme is shown in Figure 3.1 A. 
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Figure 3.1  Synthesis scheme for QAS and PQAS: (A) synthesis of QAS; (B) synthesis of 
poly(AA-co-IA), followed by tethering QAS onto the polymer. 
 
 
3.3.3  Synthesis of the Poly(acrylic acid-co-itaconic acid) with Pendent QAS 
The linear poly(acrylic acid-co-itaconic acid) or poly(AA-co-IA) was prepared 
following our published procedures [20].  Briefly, to a flask containing a solution of AA 
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(0.08 mol) and IA (0.04 mol) in 40 ml THF, AIBN (0.5 mmol) in 10 ml THF was added. 
After the reaction was run under N2 purging at 60 
o
C for 18 h, the polymer was 
precipitated with ether, followed by drying in a vacuum oven. Then B6 was tethered onto 
the purified polymer [21]. Briefly, to a solution of poly(AA-co-IA) in DMF, B6 was 
added with DCC and pyridine. The reaction was run at room temperature overnight. After 
the insoluble dicyclohexyl urea was filtered off, the formed the polymer with pendent 
QAS or PQAS was purified by precipitation from ether, washing with ether and drying in 
a vacuum oven prior to use (see Figure 3.1 B).  
 
 
3.3.4  Synthesis of the GM-tethered Star-shape Poly(acrylic acid) 
The GM-tethered 6-arm star-shape poly(acrylic acid) (PAA) was synthesized 
similarly as described in our previous publication [22]. Briefly, dipentaerythritol (0.06 
mol) in 200 ml THF was used to react with BIBB (0.48 mol) in the presence of TEA 
(0.35 mol) to form the 6-arm initiator. t-BA (0.078 mol) in 10 ml dioxane was then 
polymerized with the 6-arm initiator (1% by mole) at 120 °C in the presence of CuBr 
(3%)-PMDETA (3%) catalyst complex via ATRP. The resultant 6-arm poly(t-BA) was 
hydrolyzed with HCl and dialyzed against distilled water. The purified star-shape PAA 
was obtained via freeze-drying, followed by tethering with GM (50% by mole) in DMF 
in the presence of pyridine (1% by weight) [22]. The GM-tethered star-shape PAA was 
recovered by precipitation from diethyl ether, followed by drying in a vacuum oven at 
room temperature. The synthesis scheme for the 6-arm star-shape PAA is also shown in 
Figure 3.2. 
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Figure 3.2  Synthesis scheme for star-shape poly(acrylic acid): synthesis of the 6-arm 
star-shape poly(acrylic acid) tethered with polymerizable methacrylates. 
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3.3.5  Characterization 
The chemical structures of the synthesized QAS and PQAS were characterized by 
Fourier transform-infrared (FT-IR) spectroscopy and nuclear magnetic resonance (NMR) 
spectroscopy. The proton NMR (
1
HNMR) spectra were obtained on a 500 MHz Bruker 
NMR spectrometer (Bruker Avance II, Bruker BioSpin Corporation, Billerica, MA) using 
deuterated dimethyl sulfoxide and chloroform as solvents and FT-IR spectra were 
obtained on a FT-IR spectrometer (Mattson Research Series FT/IR 1000, Madison, WI). 
 
 
3.4  Evaluation 
 
 
3.4.1  Sample Preparation for Strength Tests 
The experimental cements were formulated with a two-component system (liquid 
and powder) [22]. The liquid was formulated with the light-curable star-shape poly(acrylic 
acid), water, 0.9% CQ (photo-initiator, by weight) and 1.8% DC (activator). The 
polymer/water (P/W) ratios (by weight) = 70:30. Fuji II LC glass powder was either used 
alone or mixed with the synthesized PQAS to formulate the cements, where the PQAS 
mixing ratio (by weight) = 1, 3, 5, 10, or 30% of the glass. The detailed formulations are 
shown in Table 3.1. Fuji II LC was used as control and prepared per manufacturer’s 
instruction where the P/L ratio = 3.2. 
 
Specimens were fabricated at room temperature according to the published 
protocol [22]. Briefly, the cylindrical specimens were prepared in glass tubing with 
dimensions of 4 mm in diameter by 8 mm in length for compressive strength (CS), 4 mm 
in diameter by 2 mm in length for diametral tensile strength (DTS), and 4 mm in diameter 
by 2 mm in depth for antibacterial tests. The rectangular specimens were prepared in a 
split Teflon mold with dimensions of 3 mm in width by 3 mm in thickness by 25 mm in 
length for flexural strength (FS) test.  All the specimens were exposed to blue light 
(EXAKT 520 Blue Light Polymerization Unit, EXAKT Technologies, Inc., Oklahoma 
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City, OK) for 2 min, followed by conditioned in 100% humidity for 15 min, removed 
from the mold and conditioned in distilled water at 37 
o
C for 24 h unless specified, prior 
to testing. 
 
 
3.4.2  Strength Measurements 
CS, DTS and FS tests were performed on a screw-driven mechanical tester (QTest 
QT/10, MTS Systems Corp., Eden Prairie, MN), with a crosshead speed of 1 mm/min. 
The FS test was performed in three-point bending, with a span of 20 mm and 16 mm, 
respectively, between supports. Six to eight specimens were tested to obtain a mean value 
for each material or formulation in each test. CS was calculated using an equation of CS 
= P/r2, where P = the load at fracture and r = the radius of the cylinder. DTS was 
determined from the relationship DTS = 2P/dt, where P = the load at fracture, d = the 
diameter of the cylinder, and t = the thickness of the cylinder. FS was obtained using the 
expression FS = 3Pl/2bd
2
, where P = the load at fracture, l = the distance between the two 
supports, b = the breadth of the specimen, and d = the depth of the specimen. 
 
 
3.4.3  MIC Test for the Synthesized QAS 
The minimal inhibitory concentration (MIC) of the synthesized QAS was 
determined following the published protocol with a slight modification. Briefly, colonies 
of S. mutans (UA159) were suspended in 5 ml of Tryptic soy Broth (TSB) prior to MIC 
testing. Two-fold serial dilutions of the synthesized QAS were prepared in TSB, followed 
by placing in 96-well flat-bottom microtiter plates with a volume of 250 μl per well. The 
final concentration of the QAS ranged from 1.563 to 2 x 10
4
 µg/ml. The microtiter plate 
was then inoculated with S. mutans suspension (cell concentration = 5 x 10
5
 CFU/ml) and 
incubated at 37 
o
C for 48 h prior to MIC testing. The absorbance was measured at 595 nm 
via a microplate reader (SpectraMax 190, Molecular Devices, CA) to assess the cell 
growth. Chloehexidine (CHX) and dimethylsulfoxide were used as positive and negative 
controls, respectively. Triple replica was used to obtain a mean value for each QAS. 
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3.4.4  Antibacterial Test for the Formed Cements 
The antibacterial test was conducted following the published procedures [23]. S. 
mutans (oral bacterial strain) was used for evaluation of antibacterial activity of the 
studied cements. Briefly, colonies of S. mutans (UA159) were suspended in 5 ml of 
Tryptic soy Broth (TSB), supplemented with 1% sucrose, to make a suspension with 10
8
 
CFU/ml of S. mutans, after 24 h incubation. Specimens pretreated with ethanol (10 sec) 
were incubated with S. mutans in TSB at 37 
o
C for 48 h under anaerobic condition with 
5% CO2. After equal volumes of the red and the green dyes (LIVE/DEAD BacLight 
bacterial viability kit L7007, Molecular Probes, Inc., Eugene, OR) were combined in a 
microfuge tube and mixed thoroughly for 1 min, 3 μl of the dye mixture was added to 1 
ml of the bacteria suspension, mixed by vortexing for 10 sec, sonicating for 10 sec as 
well as vortexing for another 10 sec, and kept in dark for about 15 min, prior to analysis. 
Then 20 μl of the stained bacterial suspension was analyzed using a fluorescent 
microscope (Nikon Microphot-FXA, Melville, NY). Triple replica was used to obtain a 
mean value for each material. 
 
 
3.4.5  Statistical Analysis 
One-way analysis of variance (ANOVA) with the post hoc Tukey-Kramer 
multiple-range test was used to determine significant differences of mechanical strength 
and antibacterial tests among the materials in each group. A level of α = 0.05 was used for 
statistical significance. 
 
 
3.5  Results and Discussion 
 
 
3.5.1  Characterization 
The characteristic chemical shifts (ppm) from the 
1
HNMR spectra (see Figure 3.3) 
for bromohexane, DMEA, B6, C6, poly(AA-co-IA) and poly(AA-co-IA) with pendent 
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QAS or PQAS are shown below: (a) bromohexane: 3.51 (-CH2Br), 1.80 (-CH2CH2Br), 
1.38 (-CH2-, all) and 0.89 (-CH3); (b) DMEA: 4.40 (-OH), 3.42 (-CH2OH), 2.30 (-CH2N-
) and 2.10 (H3CN-); (c) B6: 5.20 (-OH), 3.82 (-CH2OH), 3.45 (-CH2N(CH3)2), 3.15 
(H3CN-), 1.65 (-CH2CH2N(CH3)2), 1.25 (-CH2- all) and 0.89 (-CH3); (d) C6: 5.35 (-OH), 
3.58 (-CH2OH), 3.20 (-CH2N(CH3)2), 2.90 (H3CN-), 1.45 (-CH2CH2N(CH3)2), 1.025 (-
CH2- all) and 0.62 (-CH3); (e) poly(AA-co-IA): 12.2 (-COOH), 3.45 (-CH(COOH)-) and 
1.2-2.5 (-CH2-, all); (f) PQAS: 3.80 (-CH2(COOH)-), 3.30-3.45 (-CH2N-), 3.10 (H3CN-), 
1.65 (-CH2CH2N(CH3)2), 1.25 (-CH2- all) and 0.89 (-CH3). The appearance of all the new 
peaks in the spectrum for PQAS confirmed the successful attachment of B6 onto the 
poly(AA-co-IA). The chemical shifts for C6 appeared in a lower position than those for 
B6.    
 
The characteristic peaks (cm
-1
) from the FT-IR spectra (see Figure 3.4) for 
bromohexane, DMEA, B6, C6, poly(AA-co-IA) and PQAS are listed below: (a) 
bromohexane: 2920 (C-H stretching on -CH2-), 2851 (C-H stretching on -CH3), 1464, 
1375 and 1250 (C-H deformation on –CH2-), 721 and 647 (C-Br deformation); (b) 
DMEA: 3399 (O-H stretching), 2944 (C-H stretching on -CH2-), 2861 (C-H stretching on 
-CH3), 2820 and 2779 (C-H stretching on –N(CH3)2), 1459, 1364 and 1268 (C-H 
deformation on –CH2-), 1090 (O-H deformation), 1040 and 776 (C-N deformation); (c) 
B6: 3600-3200 (=N
+
= stretching), 2917 (C-H stretching on -CH2-), 2850 (C-H stretching 
on -CH3), 1470 (C-H deformation on –CH2-), 1090 and 730 (O-H deformation); (d) C6: 
3600-3200 (=N
+
= stretching), 2909 (C-H stretching on -CH2-), 2843 (C-H stretching on -
CH3), 1459 (C-H deformation on –CH2-), 1090 and 730 (O-H deformation); (e) poly(AA-
co-IA): 3800-2400 (O-H stretching on –COOH), 1716 (-C=O stretching), 1196-1458 (C-
H deformation on –CH2-); (f) PQAS: 3353 (=N
+
= stretching), 3800-2400 (O-H stretching 
on –COOH), 2923 (C-H stretching on -CH2-), 2853 (C-H stretching on -CH3), 1732 (-
C=O stretching), 1167-1466 (C-H deformation on –CH2-) and 776 (C-N deformation). 
The significant peaks at 3600-3200 for =N
+
= group, 2923 and 2853 for –CH2- group and 
1736 for carbonyl group confirmed the formation of PQAS. 
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Figure 3.3  
1
HNMR spectra for bromohexane, DMEA, B6, C6, poly(AA-co-IA) and 
PQAS: (a) bromohexane; (b) DMEA; (c) B6; (d) C6; (e) poly(AA-co-IA) and (f) PQAS. 
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Figure 3.4  FT-IR spectra for bromohexane, DMEA, B6, C6, poly(AA-co-IA) and PQAS: 
(a) bromohexane; (b) DMEA; (c) B6; (d) C6; (e) poly(AA-co-IA) and (f) PQAS. 
 
 
3.5.2  Evaluation 
Table 3.1 shows the code, description and MIC of the synthesized QAS. The MIC 
values ranged from 1.563 to 2 x 10
4
µg/ml for B16 to B2 and 1.563 to 100µg/ml for C16 
to C10. 
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Table 3.1  Codes, description, MIC values of the synthesized QAS  
 
Code 
QAS
1 
Chain length
 
MIC 
(μg/ml)2 
B2   2-Dimethyl-2-ethyl-1-hydroxyethylammonium bromide 2 20,000 
B6   2-Dimethyl-2-hexyl-1-hydroxyethylammonium bromide 6 1,000 
B10   2-Dimethyl-2-decyl-1-hydroxyethylammonium bromide 10 200 
B12   2-Dimethyl-2-dodecyl-1-hydroxyethylammonium bromide 12 25 
B14 2-Dimethyl-2-tetradecyl-1-hydroxyethylammonium bromide 14 3.125 
B16 2-Dimethyl-2-hexadecyl-1-hydroxyethylammonium bromide 16 1.563 
C10   2-Dimethyl-2-decyl-1-hydroxyethylammonium chloride 10 100 
C12   2-Dimethyl-2-dodecyl-1-hydroxyethylammonium chloride 12 25 
C14 2-Dimethyl-2-tetradecyl-1-hydroxyethylammonium chloride 14 1.563 
C16 2-Dimethyl-2-hexadecyl-1-hydroxyethylammonium chloride 16 1.563 
1
All the QAS were freshly synthesized and were water-soluble; 
2
MIC values were 
measured as described in the text. 
 
Table 3.2 shows the effect of the substitute chain length of the synthesized QAS 
on CS and S. mutans viability of both Fuji II LC and EXPGIC cements. Fuji II LC and 
EXPGIC without PQAS addition were used as controls. The mean CS value (MPa) was 
in the decreasing order of EXPGIC > Fuji II LC > EXPGIC (B2) > EXPGIC (B6) > 
EXPGIC (B10) > EXPGIC (B14) > Fuji II LC (B2) > Fuji II LC (B6) > Fuji II LC 
(B10) > Fuji II LC (B14), where there were no statistically significant differences among 
Fuji II LC (B2), Fuji II LC (B6), Fuji II LC (B10) and Fuji II LC (B14), between 
EXPGIC (B2) and EXPGIC (B6), and between EXPGIC (B10) and EXPGIC (B14) (p > 
0.05). The PQAS addition significantly decreased the CS values of the cements, with a 
reduction of 50-60% for Fuji II LC and 37-52% for EXPGIC. Increasing the substitute 
chain length on the QAS decreased the CS values of both cements but the decreasing rate 
was not dramatic. The mean S. mutans viability was in the decreasing order of Fuji II 
LC > EXPGIC > Fuji II LC (B2) > Fuji II LC (B6) > Fuji II LC (B10) > EXPGIC (B2) > 
Fuji II LC (B14) > EXPGIC (B6) > EXPGIC (B10) > EXPGIC (B14), where there were 
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no statistically significant differences among Fuji II LC and EXPGIC, between Fuji II LC 
(B2) and Fuji II LC (B6), among Fuji II LC (B6), Fuji II LC (B10), Fuji II LC (B14) and 
EXPGIC (B2), between Fuji II LC (B14) and EXPGIC (B6), and Between EXPGIC (B10) 
and EXPGIC (B14) (p > 0.05). The PQAS addition significantly decreased the S. mutans 
viability, with a reduction of 38-56% for Fuji II LC and 52-73% for EXPGIC. Increasing 
the substitute chain length on the QAS decreased the S. mutans viability of both cements 
but the decreasing rate was not as dramatic as the MIC values for the QAS in water (see 
Table 3.1). Moreover, the PQAS in EXPGIC showed a higher killing power to S. mutans 
than those in Fuji II LC. 
 
Figure 3.5 shows the effect of PQAS bromide and PQAS chloride on CS and S. 
mutans viability of EXPGIC. Like those in Table 3.2, increasing the substitute chain 
length on the QAS decreased the CS values of the cements and S. mutans viability. 
Although it seems that some of them were not statistically significant from each other, the 
cements formulated with PQAS bromide showed less CS reduction (see Figure 3.5a) but 
lower S. mutans viability (Figure 3.5b) than those with PQAS chloride. The results 
suggest that PQAS bromide is better than PQAS chloride. 
 
Figure 3.6 shows the effect of the PQAS loading on CS and S. mutans viability of 
EXPGIC. Increasing the PQAS loading decreased CS and S. mutans viability of EXPGIC. 
With 1 to 20% PQAS loading, EXPGIC lost 18 to 80% of its original CS but killed 17 to 
83% of S. mutans correspondingly. The more the PQAS added, the lower the CS and S. 
mutans viability. Figure 3.7 shows the effect of the QAS-grafting ratio on poly(AA-co-IA) 
on CS and S. mutan viability. Like the trend shown in Figure 3.7, increasing the QAS-
grafting ratio decreased CS and S. mutans viability of EXPGIC. With increasing the 
QAS-grafting ratio from 10 to 70%, EXPGIC lost 13 to 51% of its original CS but killed 
52 to 71% of S. mutans correspondingly.  
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Table 3.2  Effect of the chain length of the synthesized QAS on CS and S. mutans 
viability of the cements  
 
Material1 Chain length
2 CS [MPa] S. mutans viability [%] 
FIILC --- 237.9 (4.5)3 77.9 (2.7)d 
FIILC(B2) 2 117.8 (1.3)a 48.1 (2.8)e 
FIILC(B6) 6 112.3 (2.1)a 43.7 (1.3)e, f 
FIILC(B10) 10 96.1 (2.8)a 37.7 (1.4)f 
FIILC(B14) 14 95.9 (3.7)a 34.4 (1.3)f, g 
EXP --- 325.3 (4.2) 76.2 (3.5)d 
EXP(B2) 2 204.1 (3.8)b 36.4 (1.5)f 
EXP(B6) 6 198.7 (4.7)b 28.3 (0.5)g 
EXP(B10) 10 163.8 (1.2)c 23.4 (1.6)h 
EXP(B14) 14 157.5 (1.2)
c 
20.9 (0.9)h 
1
FIILC = Fuji II LC; EXP = EXPGIC; PQAS was mixed with Fuji II LC glass fillers, 
where PQAS = 7% (by weight) of glass fillers and QAG grafting ratio = 50%. For Fuji II 
LC cements, P/L = 3.2; For experimental cements, MW of the 6-arm poly(acrylic acid) = 
17,530 Daltons; Grafting ratio = 50%; P/L ratio = 2.7; P/W ratio = 70:30. B2-B14 stands 
for the QAS bromide with the substitute chain length from 2 to 14. 
2
Chain length = the 
substitute chain length on QAS. 
3
Entries are mean values with standard deviations in 
parentheses and the mean values with the same superscript letter were not significantly 
different (p > 0.05). Specimens were conditioned in distilled water at 37 
o
C for 24 h, 
followed by direct testing for CS or/and incubating with S. mutans for 48 h for 
antibacterial testing. 
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Figure 3.5  Effect of PQAS bromide and PQAS chloride on CS and S. mutans viability of 
EXPGIC: (a) The effect on CS; (b) The effect on the S. mutans viability. The description 
on QAS and the formulations of the cements can be found in Tables 1 and 2, respectively. 
Specimens were conditioned in distilled water at 37 
o
C for 24 h, followed by direct 
testing for CS or/and incubating with S. mutans for 48 h for antibacterial testing. 
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Figure 3.6  Effect of PQAS content on both CS and S. mutans viability of EXPGIC: The 
formulations were the same as those described in Figure 3.5, except for PQAS content 
change and QAS = B6 (see Table 3.2). Specimens were conditioned in distilled water at 
37 
o
C for 24 h, followed by direct testing for CS or/and incubating with S mutans for 48 h 
for antibacterial testing. 
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Figure 3.7  Effect of QAS-grafting ratio on poly(AA-co-IA) on both CS and S. mutans 
viability: The formulations were the same as those described in Figure 3.6, except for 
PQAS content = 5%. Specimens were conditioned in distilled water at 37 
o
C for 24 h, 
followed by direct testing for CS or/and incubating with S. mutans for 48 h for 
antibacterial testing. 
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Figure 3.8 shows the effect of the cement aging on CS and S. mutans viability. 
After 30-day aging in water, EXPGIC (B6) showed a slight increase in CS (statistically 
no difference) but no significant changes in the S. mutans viability. Table 3.3 shows the 
property comparison among Fuji II LC, EXPGIC and EXPGIC (B6) with 5% PQAS 
loading and 50% QAS-grafting. For YS, M and UCS or CS, the mean strength values 
were in the decreasing order of EXPGIC > Fuji II LC > EXPGIC-PQAS, where there was 
no statistically significant difference between EXPGIC-PQAS and Fuji II LC for UCS 
( p > 0.05). For DTS and FS, EXPGIC > EXPGIC-PQAS > Fuji II LC, where there were 
no significant differences between EXPGIC-PQAS and Fuji II LC for either DTS or FS 
(p > 0.05). For the S. mutans viability, Fuji II LC > EXPGIC > EXPGIC-PQAS, where 
there was no significant difference between EXPGIC and Fuji II LC (p > 0.05). 
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Figure 3.8  Effect of aging on both CS and S. mutans viability after culturing with 
experimental cements with and without PQAS addition: The formulations were the same 
as those described in Figure 3.7, except for QAS grafting ratio = 50%. The specimens 
were conditioned in distilled water for 1 day, 3 days, 1 week and 1 month, followed by 
direct testing for CS and incubating with S. mutans for 48 h for antibacterial testing. 
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Table 3.3 Comparison of properties of Fuji II LC, EXPGIC and PQAS-containing 
EXPGIC 
 
Material YS1 [MPa] M2 [GPa] UCS3 [MPa] DTS4 [MPa] FS Viability (%) 
Fuji II LC 138.4 (2.2)5 6.91 (0.42) 237.9 (4.5)a 43.4 (4.5)b 52.8 (1.9)c 77.9 (2.7)d 
EXPGIC 173.9 (7.1) 7.74 (0.04) 325.3 (4.2) 58.8 (0.2) 88.3 (2.5) 76.2 (3.5)d 
EXPGIC-PQAS 110.2 (6.0) 5.62 (0.08) 222.8 (1.9)a 49.8 (1.2)b 59.9 (2.3)c 26.7 (0.9) 
1
YS = CS at yield; 
2
M = compressive modulus; 
3
UCS = ultimate CS; 
4
DTS = diametral 
tensile strength; 
5
Entries are mean values with standard deviations in parentheses and the 
mean values with the same superscript letter were not significantly different (p > 0.05). 
Specimens were conditioned in distilled water at 37 
o
C for 24 h, followed by direct 
testing for CS or/and incubating with S. mutans for 48 h for antibacterial testing. 
 
 
3.5.3  Discussion 
Currently there is a growing interest in preventing or reducing biofilm formation 
in many biomedical areas. In preventive restorative dentistry, secondary caries is a critical 
issue and prevention of secondary caries plays a key role in long-lasting restorations [1-4]. 
PQAS represents a new trend of antimicrobial agents in biomedical applications [11, 14]. 
PQAS can be incorporated in many ways, including mixing with fillers, copolymerizing 
with other monomers and grafting onto the polymer skeletons [11-15]. The beauty of 
using QAS is that they can kill the microorganism by touch or simple contact. The 
mechanism of QAS to kill bacteria is believed to disrupt the surface membrane of 
bacteria by changing membrane permeability or surface electrostatic balance [12, 19]. 
Unlike other leachable antibacterial agents such as silver ions, antibiotics, CHX and low 
MW QAS, PQAS are not leachable due to their high MW [15]. In this regard, we 
purposely synthesized the new PQAS, incorporated it into our experimental high-strength 
cements and evaluated the CS and antibacterial function of the formed cements. 
 
It has been noticed that chain length on QAS has a significant effect on its 
antibacterial activity [12,15]. Generally speaking, there are four main processes for 
PQAS to kill bacteria and they are (1) adsorption onto the negatively charged bacterial 
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cell surface; (2) penetrating through the cell wall; (3) binding to the cytoplasmic 
membrane; and (4) disrupting the cytoplasmic membrane [15]. It has also been found that 
both positive charge density and substitute chain length are the key to the biocidal ability, 
because the high positive charge density may enhance the driving force and the long 
substitute chain may strongly interact with the cytoplasmic membranes [15].  From Table 
1, it is apparent that increasing the substitute chain length significantly increased the 
biocidal activity of the synthesized QAS. The QAS with 16-carbon substitute chain (B16 
and C16) was the highest in MIC whereas the one with 2-carbon chain (B2) was the 
lowest. In fact, the trend for the biocidal activity of the QAS in this study was similar to 
those described elsewhere [12,15], i.e., the longer the substitute chain, the higher the 
biocidal activity. There were no significant differences in biocidal activity between QAS 
bromide and QAS chloride. 
 
From the results in Table 3.2, with PQAS addition both Fuji II LC and EXPGIC 
cements showed a decrease in CS and S. mutans viability. Fuji II LC cements lost more 
CS (50-60% of its original 237 MPa) than EXPGIC did (37-52% of 325 MPa). The loss 
of CS can be attributed to the incorporated QAS because both charge and hydrophobic 
chain on the QAS did not contribute any strength enhancement to the cements. Regarding 
the S. mutans viability, we found that both Fuji II LC and EXPGIC cements without 
PQAS addition killed about 20% S. mutans, which can be attributed to the release of 
fluoride. It is known that GICs have inhibitory effects on bacteria due to its fluoride 
release [6]. With PQAS addition, both Fuji II LC and EXPGIC increased their 
antibacterial function significantly. The longer the substitute chain, the higher the 
antibacterial activity. Moreover, EXPGIC showed an even stronger antibacterial activity 
than the corresponding Fuji II LC with increasing the chain length. The possible reason 
may be explained below. Since the synthesized PQAS is composed of 50% carboxylic 
acid and 50% QAS and both components are very hydrophilic, they like to have 
interactions with other hydrophilic components from the cement in the presence of water. 
By comparing the compositions in polymer liquid, EXPGIC contains only hydrophilic 
GM-tethered poly(acrylic acid) (70%) and water (30%), whereas Fuji II LC contains a 
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substantial amount (approximately 25-35%) of partially hydrophilic 2-hydroxyethyl 
methacrylate (HEMA) and highly hydrophobic  dimethacrylaye/oligomethacrylte except 
for the linear poly(acrylic acid) (20-30%) and water (20-30%) [24]. Therefore, the highly 
hydrophilic components in EXPGIC may help the PQAS chains better extend on the 
surface of the cements but the highly hydrophobic dimethacrylaye/oligomethacrylte and 
partially hydrophobic HEMA in Fuji II LC may restrict or interfere with the extension of 
the PQAS chains on the surface. Theoretically the more the QAS exposed the higher the 
antibacterial activity anticipated. The results imply that to reach the same or similar 
antibacterial results less PQAS might be required for EXPGIC than for Fuji II LC. We 
also noticed that EXPGIC (B6) showed a higher CS than either EXPGIC (B10) or 
EXPGIC (B14) but a similar antibacterial activity to both, meaning that B6 may be the 
optimal QAS for this GIC system based on CS and antibacterial activity. 
 
QAS can be made either as QAS bromide or QAS chloride. We hypothesized that 
QAS chloride might favor the mechanical strength as compared to QAS bromide due to 
the smaller size of chlorine. However the results in Table 3.1 showed that QAS bromide 
was similar to QAS chloride in inhibition of S. mutans based on MIC test. The results in 
Figure 3.4 and Figure 3.5 also showed that the PQAS bromide-composed cements were 
better in mechanical strength and antibacterial activity than those containing PQAS 
chlorine. The results rejected our hypothesis and suggest that it is not necessary to 
convert QAS bromide to QAS chloride. We can use QAS bromide directly to develop the 
antibacterial cements. 
 
The effect of the QAS (B6) loading on CS and S. mutans activity of EXPGIC is 
shown in Figure 3.6 Apparently, the more the synthesized PQAS added the lower the CS 
values and the higher the antibacterial activity. To keep the CS value above 200 MPa and 
S. mutans viability below 30%, EXPGIC (B6) with 5% PQAS loading seemed the best 
formulation. Therefore, we chose it to examine the effect of the QAS-grafting ratio on 
poly(AA-co-IA) on both CS and S. mutans viability. The result in Fig. 3.7 shows that the 
higher the QAS-grafting ratio, the lower the CS and the higher the antibacterial activity. 
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However, both EXPGIC (B6) cements with 30% and 50% QAS-grafting ratios showed a 
CS value close to or above 220 MPa and S. mutans viability close to or below 30%. 
Which one would be the optimal or appropriate formulation depends on what level of 
antibacterial activity of the cement we would anticipate. 
 
As stated in introduction, most antibacterial dental materials rely on the release of 
chemicals or antibacterial agents including antibiotics, silver ions, zinc ions, etc [6-10]. 
However, release or slow-release can lead or has led to a reduction of mechanical 
properties of the restoratives over time, short-term effectiveness, and possible toxicity to 
surrounding tissues if the dose or release is not properly controlled [6-10]. Our hypothesis 
was to develop an antibacterial glass-ionomer cement without leachable. Otherwise, both 
strength and antibacterial function would decrease with time or aging. To confirm if the 
incorporated PQAS was not leachable, we examined both CS and antibacterial function 
of EXPGIC (containing 5% PQAS) after aging in water for 1 day, 3 days, 1 week and 1 
month. The result in Fig. 3.8 shows that there was a slight increase in CS but no change 
or no reduction in antibacterial function after one month of aging, indicating that there 
was no PQAS leaching from the cement. The reason can be attributed to the fact that the 
PQAS synthesized in this study is the polyacid-containing polymer. It is known that the 
carboxylic acid group is the key to GIC setting and salt-bridge formation. The PQAS 
polymer not only provided QAS for antibacterial function but also supplied carboxyl 
groups for salt-bridge formation. The latter helped the PQAS polymer firmly attached to 
the glass fillers. Therefore, we developed a GIC with permanent antibacterial function. 
 
Finally we compared yield strength (YS), compressive modulus (M), ultimate CS 
(or CS), diametral tensile strength (DTS), flexural strength (FS) and S. mutans viability 
of the experimental cement having the optimal formulation with those of both EXPGIC 
and Fuji II LC without any PQAS addition. The PQAS-containing experimental cement 
was 37% in YS, 27% in modulus, 31% in CS, 15% in DTS and 32% in FS lower than 
EXPGIC without PQAS addition and 20% in YS, 18% in modulus and 6% in CS lower 
but 15% in DTS and 13% in FS higher than Fuji II LC. Furthermore, the experimental 
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cement with PQAS addition was much higher in antibacterial activity than both EXPGIC 
(65% higher) and Fuji II LC (66% higher). 
 
 
3.6  Conclusions 
A novel PQAS-containing antibacterial glass-ionomer cement with permanent 
antibacterial activity has been developed. All the PQAS-containing cements showed a 
significant antibacterial activity, accompanying with an initial CS reduction. The effects 
of chain length, loading and grafting ratio of the QAS were significant. Increasing chain 
length, loading, grafting ratio significantly enhanced antibacterial activity but reduced 
initial CS of the formed cements. The antibacterial effect of the substitute chain lengths 
from free QAS seem more significant in water than those from their polymers (PQAS) 
after integrating to the cement. There was no significant difference between QAS 
bromide and QAS chloride, suggesting that we can use QAS bromide directly without 
converting bromide to chloride. The experimental cement showed less CS reduction and 
higher antibacterial activity than Fuji II LC. The long-term aging study indicates that the 
cements are permanently antibacterial with no PQAS leaching. Within the limitations of 
this study, it appears that the experimental cement is a clinically attractive dental 
restorative that can be potentially used for long-lasting restorations due to its high 
mechanical strength and permanent antibacterial function. 
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4.  CONCLUSION 
 
 
We have developed a novel PQAS-containing antibacterial glass-ionomer cement 
with permanent antibacterial function. All the PQAS-containing cements showed a 
significant antibacterial activity, accompanying with an initial CS reduction. The effects 
of chain length, loading and grafting ratio of the QAS were significant. Increasing chain 
length, loading, grafting ratio significantly enhanced antibacterial activity but reduced 
initial CS of the formed cements. The antibacterial effect of the substitute chain lengths 
from free QAS seem more significant in water than those from their polymers (PQAS) 
after integrating to the cement. There was no significant difference between QAS 
bromide and QAS chloride, suggesting that we can use QAS bromide directly without 
converting bromide to chloride. The experimental cement showed less CS reduction and 
higher antibacterial activity than Fuji II LC. The long-term aging study indicates that the 
cements are permanently antibacterial with no PQAS leaching. Within the limitations of 
this study, it appears that the experimental cement is a clinically attractive dental 
restorative that can be potentially used for long-lasting restorations due to its high 
mechanical strength and permanent antibacterial function. 
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